Table 4.
Variable | FA | NA | P value | Odds ratio (95% CI) |
---|---|---|---|---|
EQ-5D-3L | ||||
Index value: median (IQR) | 0.66 (0.19–0.80) | 1.00 (0.80–1.00) | <0.001 a | N/A |
VAS score: median (IQR) | 50 (40–65) | 85 (70–95) | <0.001 a | N/A |
Dimensions b | L1 | L2 | L3 | L1 | L2 | L3 | ||
Mobility | 30 | 41 | 0 | 56 | 15 | 0 | <0.001 a | N/A |
Self-care | 51 | 20 | 0 | 69 | 1 | 1 | <0.001 a | N/A |
Usual activities | 29 | 34 | 8 | 62 | 7 | 2 | <0.001 a | N/A |
Pain/discomfort | 11 | 41 | 19 | 48 | 20 | 3 | <0.001 a | N/A |
Anxiety/depression | 31 | 34 | 6 | 61 | 8 | 2 | <0.001 a | N/A |
HAI | ||||
Score of items 1–14: mean (95% CI) | 18.5 (15.9–21.2) | 6.6 (5.3–7.8) | <0.001 c | N/A |
Reassurance seeking: mean (95% CI) | 25.0 (20.9–29.1) | 14.0 (10.5–1765) | <0.001 c | N/A |
Avoidance: median (IQR) | 6.0 (0–17) | 0 (0–4) | 0.0024 a | N/A |
BMI: median (IQR) | 30.1 (25.7–31.6) | 26.2 (24.6–28.8) | 0.020 a | N/A |
Long-term conditions d : median (range) | 3 (0–8) | 1 (0–5) | <0.001 a | N/A |
Hypertension e , n (%) | 29 (48) | 14 (23) | 0.002 | 4.8 (1.6–19.2) |
Painful condition e , n (%) | 22 (37) | 7 (12) | 0.004 | 3.5 (1.4–10.6) |
Asthma (currently treated) e , n (%) | 17 (28) | 7 (12) | 0.033 | 2.7 (1.0–8.3) |
Irritable bowel syndrome e , n (%) | 16 (27) | 7 (12) | 0.020 | 4.0 (1.1–22.1) |
Diabetes e , n (%) | 9 (15) | 2 (3) | 0.012 | 8.0 (1.1–355.0) |
CI, confidence interval.
a Wilcoxon signed-rank tests for EQ-5D dimensions, index value and VAS, Health Anxiety Inventory (HAI) avoidance scores, BMI and long-term conditions.
b Number of participants reporting level 1 (L1; no problems), level 2 (L2; some problems) and level 3 (L3; extreme problems) for each dimension.
c Paired t -tests for HAI item 1–14 scores and reassurance seeking scores.
d Long-term physical conditions from case records as defined by Barnett et al. (22), n = 60 in both FAs and NAs.
e Long-term conditions if found in 10% or more participants in either group, McNemar’s test for all binary long-term conditions.